Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Tscholl

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
The Journal of Urology|May 1, 1995
Laparoscopic dismembered pyeloplasty: preliminary reportF Recker, B Subotic, M Goepel, et al.
Helvetica Chirurgica Acta|September 1, 1974
[Effect of allopurinol on the swine kidney ischemia time at normal body temperature]P Spreng, J Hodler, G Locher, et al.
Investigative Urology|May 1, 1975
The physical properties of polyglycolic acid sutures (Dexon) in sterile and infected urineO Sebeseri, U Keller, P Spreng, et al.
The Journal of Urology|May 1, 1995
Incidence of erectile impotence secondary to transurethral resection of benign prostatic hyperplasia, assessed by preoperative and postoperative Snap Gauge testsR Tscholl, M Largo, E Poppinghaus, et al.
The Journal of Urology|May 23, 1998
Development of testicular seminoma after previous negative biopsy for testicular intraepithelial neoplasiaM Dubs, M K Kwiatkowski, H Laeng, et al.
British Journal of Urology|May 23, 1998
Free-to-total prostate-specific antigen (PSA) ratio improves the specificity for detecting prostate cancer in patients with prostatism and intermediate PSA levelsF Recker, M K Kwiatkowski, T Piironen, et al.
The Journal of Urology|August 8, 2001
Prospective detection of clinically relevant prostate cancer in the prostate specific antigen range 1 to 3 ng./ml. combined with free-to-total ratio 20% or less: the Aarau experienceF Recker, M K Kwiatkowski, A Huber, et al.
European Urology|January 1, 1987
Adjuvant intravesical chemotherapy of superficial bladder cancer with monthly doxorubicin or intensive mitomycin. A comparison of two consecutive seriesR Ausfeld, M Beer, J P Mühlethaler, et al.
Urology|March 29, 2000
Human glandular kallikrein as a tool to improve discrimination of poorly differentiated and non-organ-confined prostate cancer compared with prostate-specific antigenF Recker, M K Kwiatkowski, T Piironen, et al.
Urology|September 8, 1998
In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic "gray zone" of total PSA 4 to 10 ng/mLM K Kwiatkowski, F Recker, T Piironen, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
The Journal of Urology|May 1, 1995
Laparoscopic dismembered pyeloplasty: preliminary reportF Recker, B Subotic, M Goepel, et al.
Helvetica Chirurgica Acta|September 1, 1974
[Effect of allopurinol on the swine kidney ischemia time at normal body temperature]P Spreng, J Hodler, G Locher, et al.
Investigative Urology|May 1, 1975
The physical properties of polyglycolic acid sutures (Dexon) in sterile and infected urineO Sebeseri, U Keller, P Spreng, et al.
The Journal of Urology|May 1, 1995
Incidence of erectile impotence secondary to transurethral resection of benign prostatic hyperplasia, assessed by preoperative and postoperative Snap Gauge testsR Tscholl, M Largo, E Poppinghaus, et al.
The Journal of Urology|May 23, 1998
Development of testicular seminoma after previous negative biopsy for testicular intraepithelial neoplasiaM Dubs, M K Kwiatkowski, H Laeng, et al.
British Journal of Urology|May 23, 1998
Free-to-total prostate-specific antigen (PSA) ratio improves the specificity for detecting prostate cancer in patients with prostatism and intermediate PSA levelsF Recker, M K Kwiatkowski, T Piironen, et al.
The Journal of Urology|August 8, 2001
Prospective detection of clinically relevant prostate cancer in the prostate specific antigen range 1 to 3 ng./ml. combined with free-to-total ratio 20% or less: the Aarau experienceF Recker, M K Kwiatkowski, A Huber, et al.
European Urology|January 1, 1987
Adjuvant intravesical chemotherapy of superficial bladder cancer with monthly doxorubicin or intensive mitomycin. A comparison of two consecutive seriesR Ausfeld, M Beer, J P Mühlethaler, et al.
Urology|March 29, 2000
Human glandular kallikrein as a tool to improve discrimination of poorly differentiated and non-organ-confined prostate cancer compared with prostate-specific antigenF Recker, M K Kwiatkowski, T Piironen, et al.
Urology|September 8, 1998
In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic "gray zone" of total PSA 4 to 10 ng/mLM K Kwiatkowski, F Recker, T Piironen, et al.
Pageof 6